# Axcelis Technologies Inc: Form 10-Q for the period ended Jun 30, 2015

- Company: [Axcelis Technologies Inc](/companies/acls.md) (CIK 1113232)
- Form: 10-Q
- Filed: 2015-08-05
- Accepted by EDGAR: Aug 5, 2015, 13:32 ET
- Period: 2015-06-30
- Accession: 0001104659-15-056360
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1113232/000110465915056360/a15-11904_110q.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1113232/000110465915056360/

## Figures reported in this filing

Standardized XBRL line items for the period ended 2015-06-30.

| Line item | Period | Value | XBRL concept |
| --- | --- | ---: | --- |
| Revenue | 3 months, 2015-04-01 to 2015-06-30 | $78.4m | us-gaap:SalesRevenueNet |
| Revenue | 6 months, 2015-01-01 to 2015-06-30 | $151.7m | us-gaap:SalesRevenueNet |
| Cost of revenue | 3 months, 2015-04-01 to 2015-06-30 | $51.3m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months, 2015-01-01 to 2015-06-30 | $101.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months, 2015-04-01 to 2015-06-30 | $27.2m | us-gaap:GrossProfit |
| Gross profit | 6 months, 2015-01-01 to 2015-06-30 | $50.6m | us-gaap:GrossProfit |
| Research and development | 3 months, 2015-04-01 to 2015-06-30 | $7.9m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months, 2015-01-01 to 2015-06-30 | $16.1m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months, 2015-04-01 to 2015-06-30 | $7.2m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months, 2015-01-01 to 2015-06-30 | $10.6m | us-gaap:OperatingIncomeLoss |
| Interest expense | 3 months, 2015-04-01 to 2015-06-30 | $1.3m | us-gaap:InterestExpense |
| Interest expense | 6 months, 2015-01-01 to 2015-06-30 | $2.4m | us-gaap:InterestExpense |
| Income tax | 3 months, 2015-04-01 to 2015-06-30 | $40.0k | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months, 2015-01-01 to 2015-06-30 | $141.0k | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months, 2015-04-01 to 2015-06-30 | $5.9m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Net income | 6 months, 2015-01-01 to 2015-06-30 | $7.8m | us-gaap:NetIncomeLossAvailableToCommonStockholdersBasic |
| Diluted EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.05 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months, 2015-01-01 to 2015-06-30 | $0.06 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months, 2015-04-01 to 2015-06-30 | $0.05 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months, 2015-01-01 to 2015-06-30 | $0.07 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months, 2015-04-01 to 2015-06-30 | 120,612,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months, 2015-01-01 to 2015-06-30 | 119,900,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months, 2015-01-01 to 2015-06-30 | $11.8m | us-gaap:NetCashProvidedByUsedInOperatingActivitiesContinuingOperations |
| Capital expenditure | 6 months, 2015-01-01 to 2015-06-30 | $672.0k | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Cash and equivalents | at 2015-06-30 | $78.1m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | at 2015-06-30 | $250.7m | us-gaap:AssetsCurrent |
| Total assets | at 2015-06-30 | $295.3m | us-gaap:Assets |
| Current liabilities | at 2015-06-30 | $60.3m | us-gaap:LiabilitiesCurrent |
| Total liabilities | at 2015-06-30 | $114.9m | us-gaap:Liabilities |
| Shareholders' equity | at 2015-06-30 | $180.4m | us-gaap:StockholdersEquity |

## Management's discussion and analysis

As filed, 27,854 characters.

### Overview

Axcelis is a worldwide producer of ion implantation and other processing equipment used in the fabrication of semiconductor chips in the United States, Europe and Asia. In addition, the Company provides extensive aftermarket service and support, including spare parts, equipment upgrades and maintenance services to the semiconductor industry worldwide. Consolidation and partnering within the semiconductor manufacturing industry has resulted in a small number of customers representing a substantial portion of our business. Our net revenue from our ten largest customers accounted for 75.4% of total revenue for the six months ended June 30, 2015.

Our product development and manufacturing activities occur primarily in the United States. Axcelis’ equipment and service products are highly technical and are sold primarily through a direct sales force in the United States, Europe and Asia.

Demand for semiconductor manufacturing equipment and services has historically been subject to cyclical industry conditions reflecting our customers’ responses to changes in the nature and timing of technological advances in fabrication processes, supply and demand for chips, and global economic and market conditions.

Separately from overall market demand, Axcelis’ results are also impacted by our customers’ decisions to purchase our products rather than our competitors’ systems. Our recent financial results reflect increasing sales of our innovative Purion ion implantation systems, and our continued investment in research and development programs related to our Purion ion implantation products. Throughout 2015 we expect to continue to grow Purion system sales and maintain tight control of our cost structure.

In light of these conditions, Axcelis’ results can vary significantly year-over-year, as well as quarter-over-quarter. A discussion of factors that could affect Axcelis’ operations is set forth under “Risk Factors” in Part II, Item 1A to our annual report on Form 10-K for the year ended December 31, 2014, which discussion is incorporated herein by reference.

### Critical Accounting Estimates

Management’s discussion and analysis of our financial condition and results of operations included herein and in our Annual Report on Form 10-K for the year ended December 31, 2014 are based upon Axcelis’ consolidated financial statements, which have been prepared in accordance with accounting principles generally accepted in the United States. The preparation of these financial statements requires management to make estimates and judgments that affect the reported amounts of assets, liabilities, revenue and expenses and related disclosure of contingent assets and liabilities. On an on-going basis, we evaluate our estimates and assumptions. Management’s estimates are based on historical experience and on various other assumptions that are believed to be reasonable under the circumstances, the results of which form the basis for making judgments about the carrying values of assets and liabilities that are not readily apparent from other sources. Actual results may differ from these estimates under different assumptions or conditions.

Management has not identified any need to make any material change in, and has not changed, any of our critical accounting estimates and judgments as described in Management’s Discussion and Analysis of Financial Conditions and Results of Operations included in our Annual Report on Form 10-K for the year ended December 31, 2014.

### Results of Operations

The following table sets forth our results of operations as a percentage of total revenue:

| Revenue: | Three months ended June 30, 2015 | 2014 | Six months ended June 30, 2015 | 2014 |
| --- | ---: | ---: | ---: | ---: |
| Product | 92.7% | 84.6% | 92.5% | 88.1% |
| Services | 7.3 | 15.4 | 7.5 | 11.9 |
| Total revenue | 100.0 | 100.0 | 100.0 | 100.0 |
| Cost of revenue: |  |  |  |  |
| Product | 59.4 | 51.1 | 60.5 | 53.8 |
| Services | 6.0 | 13.7 | 6.2 | 10.7 |
| Total cost of revenue | 65.4 | 64.8 | 66.7 | 64.5 |
| Gross profit | 34.6 | 35.2 | 33.3 | 35.5 |
| Operating expenses: |  |  |  |  |
| Research and development | 10.1 | 21.5 | 10.6 | 17.7 |
| Sales and marketing | 7.5 | 12.2 | 7.6 | 10.3 |
| General and administrative | 7.9 | 15.8 | 8.1 | 12.7 |
| Restructuring charges | 0.0 | 0.4 | 0.0 | 0.4 |
| Total operating expenses | 25.5 | 49.9 | 26.3 | 41.1 |
| Income (loss) from operations | 9.1 | (14.7) | 7.0 | (5.6) |
| Other (expense) income: |  |  |  |  |
| Interest income | 0.0 | 0.0 | 0.0 | 0.0 |
| Interest expense | (1.7) | (0.6) | (1.6) | (0.5) |
| Other, net | 0.1 | (0.9) | (0.3) | (0.1) |
| Total other expense | (1.6) | (1.5) | (1.9) | (0.6) |
| Income (loss) before income taxes | 7.5 | (16.2) | 5.1 | (6.2) |
| Income taxes | 0.1 | 0.6 | 0.1 | 0.4 |
| Net income (loss) | 7.4% | (16.8)% | 5.0% | (6.6)% |

### Revenue

The following table sets forth our revenue.

*(dollars in thousands)*

| Revenue: | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Product | $72,748 | $34,795 | $37,953 | 109.1% | $140,278 | $89,810 | $50,468 | 56.2% |
| Percentage of revenue | 92.7% | 84.6% |  |  | 92.5% | 88.1% |  |  |
| Services | 5,689 | 6,355 | (666) | (10.5)% | 11,442 | 12,180 | (738) | (6.1)% |
| Percentage of revenue | 7.3% | 15.4% |  |  | 7.5% | 11.9% |  |  |
| Total revenue | $78,437 | $41,150 | $37,287 | 90.6% | $151,720 | $101,990 | $49,730 | 48.8% |

15

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

#### Product

Product revenue, which includes system sales, sales of spare parts, product upgrades and used systems was $72.7 million, or 92.7%, of revenue during the three months ended June 30, 2015, compared with $34.8 million, or 84.6% of revenue for the three months ended June 30, 2014. The $38.0 million increase in product revenue for the three month period ending June 30, 2015 was primarily driven by an increase in the number of Purion systems sold.

A portion of our revenue from system sales is deferred until installation and other services related to future deliverables are performed. The total amount of deferred revenue at June 30, 2015 and December 31, 2014 was $8.9 million and $7.2 million, respectively. The increase in deferred revenue is primarily due to additional volume of system sales and to a lesser extent, the timing of the acceptance of system sales.

#### Services

Services revenue, which includes the labor component of maintenance and service contracts and fees for service hours provided by on-site service personnel, was $5.7 million, or 7.3% of revenue for the three months ended June 30, 2015, compared with $6.4 million, or 15.4% of revenue for the three months ended June 30, 2014. Although services revenue should increase with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

#### Product

Product revenue was $140.3 million, or 92.5% of revenue for the six months ended June 30, 2015, compared with $89.8 million, or 88.1% of revenue for the six months ended June 30, 2014. The increase in product revenue is attributable to the number of Purion systems sold.

#### Services

Services revenue was $11.4 million, or 7.5% of revenue for the six months ended June 30, 2015, compared with $12.2 million, or 11.9% of revenue for the six months ended June 30, 2014. Although services revenue should increase with the expansion of the installed base of systems, it can fluctuate from period to period based on capacity utilization at customers’ manufacturing facilities, which affects the need for equipment service.

### Revenue Categories used by Management

As an alternative to the line item revenue categories discussed above, management also uses revenue categorizations which look at revenue by systems and aftermarket, as described below.

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

#### Systems

Included in total revenue of $78.4 million during the three months ended June 30, 2015 is revenue from sales of systems of $41.6 million, or 53.0% of total revenue, compared with $10.9 million, or 26.4%, of total revenue for the three months ended June 30, 2014. The increase was due to higher sales of our Purion systems, reflecting market share gains and an improved semiconductor equipment market.

#### Aftermarket

We refer to the business of selling spare parts, product upgrades and used systems, combined with the sale of maintenance labor and service contracts and service hours, as the “aftermarket” business. Included in total revenue of $78.4 million during the three months ended June 30, 2015 is revenue from our aftermarket business of $36.9 million, compared to $30.3 million for the three months ended June 30, 2014. Aftermarket revenue fluctuates from period to period based on capacity utilization at customers’ manufacturing facilities which affects the sale of spare parts and demand for equipment service. Aftermarket revenue can also fluctuate from period to period based on the demand for system upgrades or used tools.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

#### Systems

Included in total revenue of $151.7 million during the six months ended June 30, 2015 is revenue from sales of systems of $84.1 million, or 55.4% of total revenue, compared with $43.3 million, or 42.5% of total revenue for the six months ended June 30, 2014. The increase was due to higher sales of our Purion systems, reflecting market share gains and an improved semiconductor equipment market during the first six months of 2015.

#### Aftermarket

Included in total revenue of $151.7 million during the six months ended June 30, 2015 is revenue from our aftermarket business of $67.7 million, or 44.6%, compared to $58.7 million, or 57.5% for the six months ended June 30, 2014.

### Gross Profit / Gross Margin

The following table sets forth our gross profit / gross margin.

*(dollars in thousands)*

| Gross Profit: | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Product | $26,188 | $13,774 | $12,414 | 90.1% | $48,533 | $34,987 | $13,546 | 38.7% |
| Product gross margin | 36.0% | 39.6% |  |  | 34.6% | 39.0% |  |  |
| Services | 986 | 710 | 276 | 38.9% | 2,021 | 1,237 | 784 | 63.4% |
| Services gross margin | 17.3% | 11.2% |  |  | 17.7% | 10.2% |  |  |
| Total gross profit | $27,174 | $14,484 | $12,690 | 87.6% | $50,554 | $36,224 | $14,330 | 39.6% |
| Gross margin | 34.6% | 35.2% |  |  | 33.3% | 35.5% |  |  |

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

#### Product

Gross margin from product revenue was 36.0% for the three months ended June 30, 2015, compared to 39.6% for the three months ended June 30, 2014. The decrease in gross margin of 3.6 percentage points resulted from the net effect of higher systems sales volume of new Purion systems at lower initial margins.

#### Services

Gross margin from services revenue was 17.3% for the three months ended June 30, 2015, compared to 11.2% for the three months ended June 30, 2014. The increase in gross margin is attributable to changes in the mix of service contracts and lower overall service costs.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

#### Product

Gross margin from product revenue was 34.6% for the six months ended June 30, 2015, compared to 39.0% for the six months ended June 30, 2014. The decrease in gross margin of 4.4 percentage points resulted from the net effect of higher system sales volume of new Purion systems at lower initial margins and a decreased mix of parts and upgrade revenue.

#### Services

Gross margin from services revenue was 17.7% for the six months ended June 30, 2015, compared to 10.2% for the six months ended June 30, 2014. The increase in gross margin is attributable to changes in the mix of service contracts and lower overall service costs.

### Operating Expenses

The following table sets forth our operating expenses:

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $7,899 | $8,845 | $(946) | (10.7)% | $16,098 | $18,102 | $(2,004) | (11.1)% |
| Percentage of revenue | 10.1% | 21.5% |  |  | 10.6% | 17.7% |  |  |
| Sales and marketing | 5,858 | 5,037 | 821 | 16.3% | 11,486 | 10,513 | 973 | 9.3% |
| Percentage of revenue | 7.5% | 12.2% |  |  | 7.6% | 10.3% |  |  |
| General and administrative | 6,231 | 6,494 | (263) | (4.0)% | 12,332 | 12,975 | (643) | (5.0)% |
| Percentage of revenue | 7.9% | 15.8% |  |  | 8.1% | 12.7% |  |  |
| Restructuring charges | 8 | 160 | (152) | (95.0)% | 18 | 360 | (342) | (95.0)% |
| Percentage of revenue | 0.0% | 0.4% |  |  | 0.0% | 0.4% |  |  |
| Total operating expenses | $19,996 | $20,536 | $(540) | (2.6)% | $39,934 | $41,950 | $(2,016) | (4.8)% |
| Percentage of revenue | 25.5% | 49.9% |  |  | 26.3% | 41.1% |  |  |

Our operating expenses consist primarily of personnel costs, including salaries, commissions, expected incentive plan payouts, share-based compensation and related benefits and taxes; project material costs related to the design and development of new products and enhancement of existing products; and professional fees, travel and depreciation expenses.

Personnel costs are our largest expense, representing $9.2 million and $17.8 million, or 46.0% and 44.5%, of our total operating expenses for the three and six-month periods ended June 30, 2015, respectively. For the three and six month periods ended June 30, 2014, personnel costs were $11.8 million and $24.4 million, respectively, or 58.0% and 58.7%, respectively, of our total operating expenses. The reduction in personal costs are primarily due to reductions in force in 2014.

### Research and Development

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Research and development | $7,899 | $8,845 | $(946) | (10.7)% | $16,098 | $18,102 | $(2,004) | (11.1)% |
| Percentage of revenue | 10.1% | 21.5% |  |  | 10.6% | 17.7% |  |  |

Our ability to remain competitive depends largely on continuously developing innovative technology, with new and enhanced features and systems and introducing them at competitive prices on a timely basis. Accordingly, based on our strategic plan, we establish annual R&D budgets to fund programs that we expect will drive competitive advantages.

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

Research and development expense was $7.9 million during the three months ended June 30, 2015; a decrease of $0.9 million, or 10.7%, compared with $8.8 million during the three months ended June 30, 2014. The decrease in expense is primarily due to reduced labor and material costs incurred in the current year compared to costs incurred last year associated with the rollout of our Purion platform.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

Research and development expense was $16.1 million during the six months ended June 30, 2015; a decrease of $2.0 million, or 11.1%, compared with $18.1 million during the six months ended June 30, 2014. The decrease was primarily due to lower personnel costs driven by reduced headcount from the previous year as well as a spike in labor and materials costs experienced in the prior year relating to the roll out of our Purion platform.

### Sales and Marketing

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Sales and marketing | $5,858 | $5,037 | $821 | 16.3% | $11,486 | $10,513 | $973 | 9.3% |
| Percentage of revenue | 7.5% | 12.2% |  |  | 7.6% | 10.3% |  |  |

Our sales and marketing expenses result primarily from the sale of our equipment and services through our direct sales force.

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

Sales and marketing expense was $5.9 million during the three months ended June 30, 2015; an increase of $0.8 million, or 16.3%, compared with $5.0 million during the three months ended June 30, 2014. The increase is primarily due to higher new tool evaluation costs and stock compensation expense.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

Sales and marketing expense was $11.5 million during the six months ended June 30, 2015; an increase of $1.0 million, or 9.3%, compared with $10.5 million during the six months ended June 30, 2014. The increase is primarily due to higher new tool evaluation costs and stock compensation expense.

### General and Administrative

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| General and administrative | $6,231 | $6,494 | $(263) | (4.0)% | $12,332 | $12,975 | $(643) | (5.0)% |
| Percentage of revenue | 7.9% | 15.8% |  |  | 8.1% | 12.7% |  |  |

Our general and administrative expenses result primarily from the costs associated with our executive, finance, information technology, legal and human resource functions.

#### Three Months Ended June 30, 2015 Compared with Three Months Ended June 30, 2014

General and administrative expense was $6.2 million during the three months ended June 30, 2015; a decrease of $0.3 million, or 4.0%, compared with $6.5 million during the three months ended June 30, 2014. The decrease was primarily due to a reduction in professional fees.

#### Six Months Ended June 30, 2015 Compared with Six Months Ended June 30, 2014

General and administrative expense was $12.3 million during the six months ended June 30, 2015; a decrease of $0.6 million, or 5.0%, compared with $13.0 million during the six months ended June 30, 2014. The decrease was primarily due to reductions in personnel costs associated with a reduction in headcount and professional fees.

### Restructuring Charges

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Restructuring charges | $8 | $160 | $(152) | (95.0)% | $18 | $360 | $(342) | (95.0)% |
| Percentage of revenue | 0.0% | 0.4% |  |  | 0.0% | 0.4% |  |  |

We implemented reductions in force in prior periods to improve the focus of our operations, control costs, achieve profitability and conserve cash. As a result of these actions, we recorded minor adjustments to restructuring expense in the three and six months periods ended June 30, 2015, compared to $0.2 million and 0.3 million during the three months and six months periods ended June 30, 2014, respectively.

### Other (Expense) Income

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Other (expense) income | $(1,255) | $(617) | $(638) | (103.4)% | $(2,728) | $(574) | $(2,154) | (375.3)% |
| Percentage of revenue | (1.6)% | (1.5)% |  |  | (1.8)% | (0.6)% |  |  |

Other (expense) income consists primarily of foreign exchange gains and losses attributable to fluctuations against local currencies of the countries in which we operate, interest earned on our invested cash balances, bank fees associated with our financing arrangements and interest expense related to financing arrangements. Other expense was $1.3 million for the three months ended June 30, 2015, compared with $0.6 million for the three months ended June 30, 2014. The increase in other expense was primarily driven by charges incurred related to the sale of our corporate headquarters facility. The Company recorded $1.3 million in interest expense associated with the lease of our headquarters in Beverly, which is being accounted for as a financing obligation. See Note 3 for further discussion.

The $2.2 million increase in other expense for the six month period ended June 30, 2015 compared with the six month period ended June 30, 2014, was primarily due to the $2.4 million interest expense recorded associated with the lease of our headquarters in Beverly. See Note 3 for further discussion.

During the three and six-month periods ended June 30, 2015 and 2014, with the exception of the lease agreement entered into by the Company relating to the sale leaseback transaction, we had no significant off-balance-sheet risk such as exchange contracts, option contracts or other foreign hedging arrangements.

### Income Taxes

*(dollars in thousands)*

|  | Three months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  | Six months ended June 30, 2015 | 2014 | Period-to-Period Change $% |  |
| --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Income taxes | $40 | $231 | $(191) | (82.7)% | $141 | $426 | $(285) | (66.9)% |
| Percentage of revenue | 0.0% | 0.6% |  |  | 0.0% | 0.4% |  |  |

We incur income tax expense relating principally to operating results of foreign entities in Europe and Asia, where we earn taxable income. We have significant net operating loss carryforwards in the United States and certain European tax jurisdictions and, as a result, we do not currently pay significant income taxes in those jurisdictions. Additionally, we do not recognize the tax benefit for such losses in the United States and certain European taxing jurisdictions until there is sufficient income such that the tax benefits can be recognized. As stated in Note 3, the Company does not anticipate any federal or state tax liability associated with the taxable gain on the sale of its corporate headquarters. The Company will continue to maintain a full valuation allowance for these tax assets until sustainable future levels of profitability are evident.

### Liquidity and Capital Resources

Our liquidity is primarily affected by the rate of sale of our products. Our established cost structure, other than cost of goods sold, does not vary significantly with changes in volume. We experience fluctuations in operating results and cash flows depending largely on changes in revenue levels.

During the six month period ended June 30, 2015, the Company generated $11.8 million of cash from operating activities. This was predominately driven by the Company’s income from operations, excluding non-cash charges such as depreciation and amortization and stock based compensation expense. The Company also had increases in accounts payable and deferred revenue of approximately $22.9 million, offset by the increases in inventory and prepaid expenses and other current assets of approximately $21.6 million. In comparison, during the six month period ended June 30, 2014, the Company used $11.9 million of cash to support operating activities.

Investing activities for the six months periods ending June 30, 2015 and 2014 included $0.7 million and $0.6 million, respectively, used for capital expenditures.

Financing activities for the six month period ending June 30, 2015 provided net cash of $35.8 million. This resulted largely from the first quarter 2015 sale of our corporate headquarters building in Beverly, Massachusetts, which provided $48.9 million of gross proceeds, less $0.4 million for prepaid rent, for a net amount of $48.5 million. Also in the first quarter, the Company paid $14.5 million to Northern Bank & Trust Company relating to a scheduled principal payment on a term loan, followed by a discharge of the loan, which was secured by the property sold. This loan discharge resulted in a $0.8 million decrease in our restricted cash balance. The Company incurred $0.8 million of related financing expenses associated with this transaction. Also included in cash provided by financing activities in the six month period was $1.9 million received relating to the exercise of stock options and purchases of Company stock through the Employee Stock Purchase Plan. In comparison, financing activities for the six month period ending June 30, 2014 included $1.8 million of cash received, primarily upon exercise of stock options.

Our revolving credit facility with Silicon Valley Bank provides for borrowings of up to $10.0 million on a revolving basis during a two year term ending October 31, 2015, based primarily on accounts receivable. The Company’s ability to borrow under this line of credit is limited to 80% of the then current amount of qualified accounts receivable. As of June 30, 2015, the Company had not drawn down on the line of credit, although a portion of the availability is being used to support outstanding letters of credit in the amount of $6.9 million. At June 30, 2015, our available borrowing capacity under the credit facility was $3.1 million and we were in compliance with all covenants related to the credit facility. The revolving credit facility is used by the Company to support letters of credit and for short-term borrowing, as needed.

We believe that based on our current market, revenue, expense and cash flow forecasts, our existing cash, cash equivalents and borrowing capacity will be sufficient to satisfy our anticipated cash requirements for the short and long-term. In the event that demand for our products declines in future periods, we believe we can align manufacturing and operating spending levels to the changing business conditions and provide sufficient liquidity to support operations. Our expectation for adequate liquidity is subject to risks that may cause our actual results to differ materially from our expectations. These risks include the timing and degree of customer acceptance of our products, the continuing demand for ion implantation equipment, overall activity levels of semiconductor manufacturing, competitive pressure on sales and pricing, increases in material and other production costs that cannot be recouped in product pricing and global economic, political and financial conditions.

### Commitments and Contingencies

Other than the lease obligation related to the sale leaseback of our Corporate headquarters shown in the table below, significant commitments and contingencies at June 30, 2015 are consistent with those discussed in Item 7, “Management’s Discussion and Analysis of Financial Condition and Results of Operations,” and Note 16 to the consolidated financial statements in our Annual Report on Form 10-K for the fiscal year ended December 31, 2014.

The following represents all material changes from our prior year end to our contractual obligations as of June 30, 2015 (in thousands):

| Contractual Obligations | Total | Payments Due by Period 2015 | 2016-2019 | 2020-2037 |
| --- | ---: | ---: | ---: | ---: |
| Lease obligation | $133,111 | $2,350 | $21,194 | $109,567 |
| Total | $133,111 | $2,350 | $21,194 | $109,567 |

22

## Market risk

As filed, 199 characters.

As of June 30, 2015, there have been no material changes to the quantitative information about market risk disclosed in Item 7A to our annual report on Form 10-K for the year ended December 31, 2014.

## Controls and procedures

As filed, 1,032 characters.

### Evaluation of Disclosure Controls and Procedures

Our management, with the participation of our principal executive officer and principal financial officer, has evaluated the effectiveness of our disclosure controls and procedures (as defined in Rule 13a-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”) as of the end of the period covered by this report (the “Evaluation Date”). Based on this evaluation, our principal executive officer and principal financial officer concluded that, as of the Evaluation Date, these disclosure controls and procedures are effective.

### Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting (as defined in Rule 13a-15(f) under the Exchange Act) identified in connection with the evaluation of our internal control that occurred during the three months ended June 30, 2015 that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

## Risk factors

As filed, 169 characters.

As of June 30, 2015, there have been no material changes to the risk factors described in Item 1A to our annual report on Form 10-K for the year ended December 31, 2014.

Filed Aug 5, 2015.
Source: SEC EDGAR, the filing index for accession 0001104659-15-056360. Last ingested by Listed: Nov 13, 2026, 17:24 ET. No prices; not investment advice.
